Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
EHC Stock Forecast 2026-2027
$100.50
Current Price
$10.12B
Market Cap
Buy 13
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to EHC Price Targets
+59.2%
To High Target of $160.00
+39.3%
To Median Target of $140.00
+24.4%
To Low Target of $125.00
EHC Price Momentum
-2.2%
1 Week Change
-5.5%
1 Month Change
+6.1%
1 Year Change
-5.3%
Year-to-Date Change
-21.5%
From 52W High of $127.99
+8.6%
From 52W Low of $92.53
📊 TOP ANALYST CALLS
Did EHC Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Encompass Health is one of their latest high-conviction picks.
Latest EHC Stock Price Targets & Analyst Predictions
Based on our analysis of 21 Wall Street analysts, EHC has a bullish consensus with a median price target of $140.00 (ranging from $125.00 to $160.00). The overall analyst rating is Strong Buy (9.7/10). Currently trading at $100.50, the median forecast implies a 39.3% upside. This outlook is supported by 13 Buy, 0 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Kevin Fischbeck at B of A Securities, projecting a 59.2% upside. Conversely, the most conservative target is provided by Ben Hendrix at RBC Capital, suggesting a 24.4% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
EHC Analyst Ratings
13
Buy
0
Hold
0
Sell
EHC Price Target Range
Low
$125.00
Average
$140.00
High
$160.00
Current: $100.50
Latest EHC Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for EHC.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Oct 30, 2025 | Barclays | Andrew Mok | Overweight | Maintains | $150.00 |
| Oct 2, 2025 | UBS | A.J. Rice | Buy | Maintains | $150.00 |
| Sep 16, 2025 | Keybanc | Matthew Gillmor | Overweight | Maintains | $140.00 |
| Sep 10, 2025 | B of A Securities | Kevin Fischbeck | Buy | Maintains | $160.00 |
| Aug 14, 2025 | Truist Securities | David Macdonald | Buy | Maintains | $140.00 |
| Aug 6, 2025 | UBS | Andrew Mok | Buy | Maintains | $140.00 |
| Jun 5, 2025 | Stephens & Co. | Raj Kumar | Overweight | Reiterates | $135.00 |
| May 27, 2025 | Keybanc | Paul Knight | Overweight | Maintains | $135.00 |
| Apr 28, 2025 | Truist Securities | David Macdonald | Buy | Reiterates | $135.00 |
| Apr 28, 2025 | RBC Capital | Ben Hendrix | Outperform | Maintains | $125.00 |
| Apr 28, 2025 | UBS | Andrew Mok | Buy | Maintains | $130.00 |
| Apr 25, 2025 | Keybanc | Matthew Gillmor | Overweight | Maintains | $122.00 |
| Apr 25, 2025 | Barclays | Andrew Mok | Overweight | Maintains | $129.00 |
| Feb 11, 2025 | RBC Capital | Ben Hendrix | Outperform | Reiterates | $110.00 |
| Feb 10, 2025 | Keybanc | Matthew Gillmor | Overweight | Maintains | $120.00 |
| Feb 7, 2025 | Barclays | Andrew Mok | Overweight | Maintains | $118.00 |
| Oct 30, 2024 | RBC Capital | Ben Hendrix | Outperform | Maintains | $110.00 |
| Oct 30, 2024 | Truist Securities | David Macdonald | Buy | Reiterates | $116.00 |
| Oct 29, 2024 | Barclays | Andrew Mok | Overweight | Maintains | $116.00 |
| Oct 29, 2024 | Keybanc | Matthew Gillmor | Overweight | Maintains | $117.00 |
Encompass Health Corporation (EHC) Competitors
The following stocks are similar to Encompass Health based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
EHC
Encompass Health
mkt cap
10.12B
Encompass Health Corporation (EHC) Financial Data
Encompass Health Corporation has a market capitalization of $10.12B with a P/E ratio of 18.9x. The company generates $5.80B in trailing twelve-month revenue with a 9.3% profit margin.
Revenue growth is +9.4% quarter-over-quarter, while maintaining an operating margin of +16.5% and return on equity of +24.4%.
Valuation Metrics
Market Cap
$10.12B
Enterprise Value
$13.54B
P/E Ratio
18.9x
PEG Ratio
1.1x
Price/Sales
1.7x
Growth & Margins
Revenue Growth (YoY)
+9.4%
Gross Margin
+95.6%
Operating Margin
+16.5%
Net Margin
+9.3%
EPS Growth
+16.9%
Financial Health
Cash/Price Ratio
+0.5%
Current Ratio
1.1x
Debt/Equity
83.5x
ROE
+24.4%
ROA
+9.4%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Encompass Health Corporation (EHC) Business Model
About Encompass Health Corporation
What They Do
Provides post-acute healthcare services in the U.S.
Business Model
Encompass Health generates revenue through its network of inpatient rehabilitation hospitals, home health agencies, and hospice agencies. The company focuses on high-quality, cost-effective care, which enhances patient outcomes and addresses the growing demand for recovery solutions after severe illnesses, surgeries, or injuries.
Additional Information
The company plays a vital role in the healthcare sector, particularly in rehabilitation and post-acute care, facilitating seamless transitions from hospital to recovery and long-term care. This positions Encompass Health as a key player in modernizing healthcare delivery systems.
Company Information
Sector
Healthcare
Industry
Medical Care Facilities
Employees
28,678
CEO
Mr. Mark J. Tarr
Country
United States
IPO Year
2017
Website
www.encompasshealth.comEncompass Health Corporation (EHC) Latest News & Analysis
Latest News
Quick Summary
Encompass Health Corp. (NYSE: EHC) will release its Q4 2025 results on February 5, 2026, after market close.
Why It Matters
Encompass Health's upcoming earnings report could impact stock performance, investor sentiment, and market expectations, influencing trading decisions and valuation assessments.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
Zacks Premium offers Style Scores to help investors identify strong stocks across value, growth, and momentum strategies.
Why It Matters
Zacks Style Scores enhance stock selection across investment strategies, potentially improving portfolio performance and attracting more investors to the Zacks Premium service.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Hospitals are facing challenges due to regulatory shifts and economic pressures, impacting their operations and financial stability in the healthcare sector.
Why It Matters
Regulatory changes and economic pressures in healthcare can impact hospital profitability, affecting stock performance and investment strategies in the sector.
Source: Benzinga
Market Sentiment:
Negative
Quick Summary
Encompass Health (EHC) has been upgraded to Zacks Rank #2 (Buy), indicating growing optimism about its earnings prospects.
Why It Matters
Encompass Health's upgrade to Zacks Rank #2 signals positive earnings expectations, potentially boosting investor confidence and driving stock price upward.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
EHC is expanding its rehabilitation hospital network, benefiting from strong cash flow and increasing patient volumes, which enhances its market position.
Why It Matters
EHC's expansion and strong cash flow signal robust growth, enhancing competitiveness and potential profitability, which can positively impact stock performance and investor confidence.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
The Zacks Medical - Outpatient and Home Healthcare industry is expected to grow due to an aging population and increased AI adoption, benefiting companies like EHC, DVA, OPCH, and PNTG.
Why It Matters
The aging population and increased AI adoption signal growth in the outpatient and home healthcare sector, benefiting companies like EHC, DVA, OPCH, and PNTG.
Source: Zacks Investment Research
Market Sentiment:
Positive
Frequently Asked Questions About EHC Stock
What is Encompass Health Corporation's (EHC) stock forecast for 2026?
Based on our analysis of 21 Wall Street analysts, Encompass Health Corporation (EHC) has a median price target of $140.00. The highest price target is $160.00 and the lowest is $125.00.
Is EHC stock a good investment in 2026?
According to current analyst ratings, EHC has 13 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $100.50. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for EHC stock?
Wall Street analysts predict EHC stock could reach $140.00 in the next 12 months. This represents a 39.3% increase from the current price of $100.50. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Encompass Health Corporation's business model?
Encompass Health generates revenue through its network of inpatient rehabilitation hospitals, home health agencies, and hospice agencies. The company focuses on high-quality, cost-effective care, which enhances patient outcomes and addresses the growing demand for recovery solutions after severe illnesses, surgeries, or injuries.
What is the highest forecasted price for EHC Encompass Health Corporation?
The highest price target for EHC is $160.00 from Kevin Fischbeck at B of A Securities, which represents a 59.2% increase from the current price of $100.50.
What is the lowest forecasted price for EHC Encompass Health Corporation?
The lowest price target for EHC is $125.00 from Ben Hendrix at RBC Capital, which represents a 24.4% increase from the current price of $100.50.
What is the overall EHC consensus from analysts for Encompass Health Corporation?
The overall analyst consensus for EHC is bullish. Out of 21 Wall Street analysts, 13 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $140.00.
How accurate are EHC stock price projections?
Stock price projections, including those for Encompass Health Corporation, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: January 19, 2026 5:20 AM UTC